Literature DB >> 10455275

Quantitation of extracellular UTP using a sensitive enzymatic assay.

E R Lazarowski1, T K Harden.   

Abstract

The wide distribution of the uridine nucleotide-activated P2Y2, P2Y4 and P2Y6 receptors suggests a role for UTP as an important extracellular signalling molecule. However, direct evidence for UTP release and extracellular accumulation has been addressed only recently due to the lack of a sensitive assay for UTP mass. In the present study, we describe a method that is based on the uridinylation of [14C]-glucose-1P by the enzyme UDP-glucose pyrophosphorylase which allows quantification of UTP in the sub-nanomolar concentration range. The UTP-dependent conversion of [14C]-glucose-1P to [14C]-UDP-glucose was made irreversible by including the pyrophosphate scavenger inorganic pyrophosphatase in the reaction medium and [14C]-glucose-1P and [14C]-UDP-glucose were separated and quantified by HPLC. Formation of [14C]-UDP-glucose was linearly observed between 1 and 300 nM UTP. The reaction was highly specific for UTP and was unaffected by a 1000 fold molar excess of ATP over UTP. Release of UTP was measured with a variety of cells including platelets and leukocytes, primary airway epithelial cells, rat astrocytes and several cell lines. In most resting attached cultures, extracellular UTP concentrations were found in the low nanomolar range (1-10 nM in 0.5 ml medium bathing 2.5 cm2 dish). Up to a 20 fold increase in extracellular UTP levels was observed in cells subjected to a medium change. Extracellular UTP levels were 10-30% of the ATP levels in both resting and mechanically-stimulated cultured cells. In unstirred platelets, a 1:100 ratio UTP/ ATP was observed. Extracellular UTP and ATP increased 10 fold in thrombin-stimulated platelets. Detection of UTP in nanomolar concentrations in the medium bathing resting cultures suggests that constitutive release of UTP may provide a mechanism of regulation of the basal activity of uridine nucleotide sensitive receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455275      PMCID: PMC1566126          DOI: 10.1038/sj.bjp.0702654

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Molecular cloning and functional analysis of a novel P2 nucleotide receptor.

Authors:  K Chang; K Hanaoka; M Kumada; Y Takuwa
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

2.  Sequence differences between human muscle and liver cDNAs for UDPglucose pyrophosphorylase and kinetic properties of the recombinant enzymes expressed in Escherichia coli.

Authors:  R G Duggleby; Y C Chao; J G Huang; H L Peng; H Y Chang
Journal:  Eur J Biochem       Date:  1996-01-15

Review 3.  Trophic roles of P2 purinoceptors in central nervous system astroglial cells.

Authors:  M P Abbracchio; S Ceruti; C Bolego; L Puglisi; G Burnstock; F Cattabeni
Journal:  Ciba Found Symp       Date:  1996

Review 4.  Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.

Authors:  G R Dubyak; C el-Moatassim
Journal:  Am J Physiol       Date:  1993-09

5.  Cloning and functional expression of a human uridine nucleotide receptor.

Authors:  D Communi; S Pirotton; M Parmentier; J M Boeynaems
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

6.  Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.

Authors:  R A Nicholas; W C Watt; E R Lazarowski; Q Li; K Harden
Journal:  Mol Pharmacol       Date:  1996-08       Impact factor: 4.436

7.  UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor.

Authors:  E R Lazarowski; A M Paradiso; W C Watt; T K Harden; R C Boucher
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells.

Authors:  M W Verghese; T B Kneisler; J A Boucheron
Journal:  J Biol Chem       Date:  1996-06-28       Impact factor: 5.157

9.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.

Authors:  C E Parr; D M Sullivan; A M Paradiso; E R Lazarowski; L H Burch; J C Olsen; L Erb; G A Weisman; R C Boucher; J T Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene.

Authors:  T Nguyen; L Erb; G A Weisman; A Marchese; H H Heng; R C Garrad; S R George; J T Turner; B F O'Dowd
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

View more
  46 in total

1.  Nucleotide-mediated relaxation in guinea-pig aorta: selective inhibition by MRS2179.

Authors:  Robert A Kaiser; Iain L O Buxton
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  P2Y(AC)(-)-receptor agonists enhance the proliferation of rat C6 glioma cells through activation of the p42/44 mitogen-activated protein kinase.

Authors:  P Claes; B Grobben; K Van Kolen; D Roymans; H Slegers
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis.

Authors:  Marko Kaulich; Ramatullah Qurishi; Christa E Müller
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

4.  Purine receptors and Ca(2+) signalling in the human blood-brain barrier endothelial cell line hCMEC/D3.

Authors:  Willem Bintig; Daniela Begandt; Barbara Schlingmann; Linda Gerhard; Maria Pangalos; Lutz Dreyer; Natalija Hohnjec; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Anaclet Ngezahayo
Journal:  Purinergic Signal       Date:  2011-09-29       Impact factor: 3.765

Review 5.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

6.  Cell surface adenylate kinase activity regulates the F(1)-ATPase/P2Y (13)-mediated HDL endocytosis pathway on human hepatocytes.

Authors:  A C S Fabre; P Vantourout; E Champagne; F Tercé; C Rolland; B Perret; X Collet; R Barbaras; L O Martinez
Journal:  Cell Mol Life Sci       Date:  2006-12       Impact factor: 9.261

7.  UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes.

Authors:  Tina M Kringelbach; Derya Aslan; Ivana Novak; Peter Schwarz; Niklas R Jørgensen
Journal:  Purinergic Signal       Date:  2013-12-28       Impact factor: 3.765

8.  UTP regulation of ion transport in alveolar epithelial cells involves distinct mechanisms.

Authors:  Chuanxiu Yang; Lijing Su; Yang Wang; Lin Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-19       Impact factor: 5.464

Review 9.  Regulation of renal NaCl and water transport by the ATP/UTP/P2Y2 receptor system.

Authors:  Volker Vallon; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-29

10.  P2Y2 receptor activation inhibits the expression of the sodium-chloride cotransporter NCC in distal convoluted tubule cells.

Authors:  P Gailly; M Szutkowska; E Olinger; H Debaix; F Seghers; S Janas; V Vallon; O Devuyst
Journal:  Pflugers Arch       Date:  2014-01-25       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.